
Health Alert Network (HAN) - 00499 | Limited Availability of Nirsevimab in the United States—Interim CDC Recommendations to Protect Infants from Respiratory Syncytial Virus (RSV) during the 2023–2024 Respiratory Virus Season
<a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE5hLS1aNVhJLWxldFdBcVF0N0F3dmFvMnN6WmVycEFmcUYydEppT3czQURrQm1oemVTNDdDcS0xX0Iza1luZzlWMm54MXhxdTIxRDZKSA?oc=5" target="_blank">Health Alert Network (HAN) - 00499 | Limited Availability of Nirsevimab in the United States—Interim CDC Recommendations to Protect Infants from Respiratory Syncytial Virus (RSV) during the 2023–2024 Respiratory Virus Season</a>&nbsp;&nbsp;<font color="#6f6f6f">Centers for Disease Control and Prevention | CDC (.gov)</font>

